Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Nattermann

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
International Journal of Cancer|July 20, 2020
The "unnatural" history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillanceAysel Ahadova, Toni T Seppälä, Christoph Engel, et al.
Familial Cancer|May 5, 2025
Colonoscopy findings in CDH1 carriers from a multicenter international studyArjun Chatterjee, Robert Hüneburg, Qijun Yang, et al.
Zeitschrift Fur Gastroenterologie|November 19, 2019
[Current recommendations for surveillance, risk reduction and therapy in Lynch syndrome patients]Robert Hüneburg, Stefan Aretz, Reinhard Büttner, et al.
Nature Communications|September 16, 2016
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis CKhaled Thabet, Anastasia Asimakopoulos, Maryam Shojaei, et al.
Plos Medicine|September 21, 2011
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional studyVijayaprakash Suppiah, Silvana Gaudieri, Nicola J Armstrong, et al.
Journal of Hepatology|November 13, 2024
HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replicationTatjana Schwarz, Johannes Ptok, Maximilian Damagnez, et al.
International Journal of Cancer|October 10, 2022
Is HLA type a possible cancer risk modifier in Lynch syndrome?Aysel Ahadova, Johannes Witt, Saskia Haupt, et al.
Journal of Hepatology|November 24, 2015
FibroGENE: A gene-based model for staging liver fibrosisMohammed Eslam, Ahmed M Hashem, Manuel Romero-Gomez, et al.
The Lancet. Gastroenterology & Hepatology|July 21, 2024
An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trialOswaldo Ortiz, Maria Daca-Alvarez, Liseth Rivero-Sanchez, et al.
The Journal of Pathology|July 21, 2017
Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndromeHans Binder, Lydia Hopp, Michal R Schweiger, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
International Journal of Cancer|July 20, 2020
The "unnatural" history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillanceAysel Ahadova, Toni T Seppälä, Christoph Engel, et al.
Familial Cancer|May 5, 2025
Colonoscopy findings in CDH1 carriers from a multicenter international studyArjun Chatterjee, Robert Hüneburg, Qijun Yang, et al.
Zeitschrift Fur Gastroenterologie|November 19, 2019
[Current recommendations for surveillance, risk reduction and therapy in Lynch syndrome patients]Robert Hüneburg, Stefan Aretz, Reinhard Büttner, et al.
Nature Communications|September 16, 2016
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis CKhaled Thabet, Anastasia Asimakopoulos, Maryam Shojaei, et al.
Plos Medicine|September 21, 2011
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional studyVijayaprakash Suppiah, Silvana Gaudieri, Nicola J Armstrong, et al.
Journal of Hepatology|November 13, 2024
HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replicationTatjana Schwarz, Johannes Ptok, Maximilian Damagnez, et al.
International Journal of Cancer|October 10, 2022
Is HLA type a possible cancer risk modifier in Lynch syndrome?Aysel Ahadova, Johannes Witt, Saskia Haupt, et al.
Journal of Hepatology|November 24, 2015
FibroGENE: A gene-based model for staging liver fibrosisMohammed Eslam, Ahmed M Hashem, Manuel Romero-Gomez, et al.
The Lancet. Gastroenterology & Hepatology|July 21, 2024
An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trialOswaldo Ortiz, Maria Daca-Alvarez, Liseth Rivero-Sanchez, et al.
The Journal of Pathology|July 21, 2017
Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndromeHans Binder, Lydia Hopp, Michal R Schweiger, et al.
Pageof 16